Scientific Advisor, Yun H. Choe, Ph.D., chaired a roundtable session for “Regulatory Perspectives in Drug Approval Process” at the 2014 Fall Symposium of the Korean American Society in Biotech and Pharmaceuticals (KASBP) - Lucas & Mercanti, LLP

Scientific Advisor, Yun H. Choe, Ph.D., chaired a roundtable session for “Regulatory Perspectives in Drug Approval Process” at the 2014 Fall Symposium of the Korean American Society in Biotech and Pharmaceuticals (KASBP)

11/08/2014 | Lucas & Mercanti, LLP

On November 8, 2014, at the 2014 Fall Symposium of the Korean American Society in Biotech and Pharmaceuticals (KASBP), Yun H. Choe, Ph.D, Scientific Advisor at the law firm of Lucas & Mercanti LLP, chaired the roundtable session for “Regulatory Perspectives in Drug Approval Process.” Dr. Choe was also a member of the Symposium Organizing Committee. On November 8, 2014, at the 2014 Fall Symposium of the Korean American Society in Biotech and Pharmaceuticals (KASBP), Yun H. Choe, Ph.D, Scientific Advisor at the law firm of Lucas & Mercanti LLP, chaired the roundtable session for “Regulatory Perspectives in Drug Approval Process.” Dr. Choe was also a member of the Symposium Organizing Committee.

Joining Dr. Choe in the roundtable discussion were attendees from Daewoong Pharmaceuticals, Inc., Green Cross, and regulatory science experts in the field. The participants on the roundtable session discussed several FDA guidelines to meet the major challenges of getting new and generic drugs to U.S. market.

KASBPis a Korean-American professional community of industrial and academic scientists and business leaders in biotechnology and pharmaceuticals. Dr. Choe is the organization’s 1st Vice President. She can be reached at ychoe@lmiplaw.com.

Leave a Reply